Skip to content
Maimon Research LLC

  • Home
  • Distance Education Programs
  • Programs For Purchase
  • Working Papers
  • Questions and Answers
Latest Working Papers

Extended Nonsense from ICER: Changing Assumptions for Takhzyro and CI Inhibitors

August 14, 2021 Dr Paul Langely 697 Views

Paul C. Langley, Ph.D., Adjunct Professor College of Pharmacy, University of Minnesota, MN

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.
Working-Paper-No.-14-August-2021Download
  • Where Bliss in Ignorance: The Institute for Clinical and Economic Review (ICER), the Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago and Imaginary Claims for Mavacamten in Hypertrophic Cardiomyopathy
  • Next Generation Quality of Life Measures

DIRECT LINKS

  • LATENT CONSTRUCTS
  • RASCH POSSESSION
  • RASCH NUMBER LINE
  • NUMERICAL STORYTELLING
  • OBJECTIVE KNOWLEDGE
  • LOGIT RATIO SCALE
  • IMPOSSIBLE QALY
  • IMPOSSIBLE REFERENCE CASE
  • VALUE CLAIMS
  • CHEERS 2022 GUIDELINE

Most Viewed Working Papers

  • CORE VALUE CLAIMS, PROTOCOLS AND FORMULARY EVALUATIONS
  • NOTHING TO CHEER ABOUT: ENDORSING IMAGINARY ECONOMIC EVALUATIONS
  • AN ORDINAL OVERSIGHT: ABANDONING THE TUFTS
  • FUNDAMENTAL MEASUREMENT AND THERAPY RESPONSE
  • VALUE CLAIMS AND THE NEW START IN RARE DISEASE
  • REJECTING PSEUDOSCIENCE: TEN COMMANDMENTS
  • EVIDENTIARY STANDARDS FOR PATIENT-CENTRIC CORE IMPACT
  • DAMAGED GOODS: IMAGINARY ICER VALUE ASSESSMENTS
  • MEASUREMENT AND RESPONSE TO THERAPY
Copyright © 2025 Maimon Research LLC. All rights reserved.
Privacy Policy